Lidocaine 5% patch 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FHYS7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,062
Award facts
- Contract value 100% obligated
- $5,062.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Lidocaine 5% Patch 30s with a ceiling value of $5,062.40 under a firm fixed-price arrangement. This delivery order, awarded on November 27, 2025, with an ultimate completion date of November 28, 2025, was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award will be performed at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The underlying IDC, awarded November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system, including specialty products, biologics, vaccines, and routine pharmaceuticals supporting DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FHYS7?
SPE2DR26FHYS7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 27, 2025.
How much is contract SPE2DR26FHYS7 worth?
The government has obligated $5,062 on SPE2DR26FHYS7.
Is contract SPE2DR26FHYS7 an order under another contract?
Yes. SPE2DR26FHYS7 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHYS7 competed?
The extent of competition for SPE2DR26FHYS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award